A drug such as Humira® (adalimumab) is typically reserved for those patients who have failed to improve on other medications including methotrexate, leflunomide (Arava©), or sulfasalazine.
Iyeza elinjengeHumira® (adalimumab) lilungiselelwe ngokukodwa izigulana ezimeko yazo ingakhange iphucuke xa zisebenzisa amanye amayeza aquka imethotrexate, ileflunomide (Arava©), okanye isulfasalazine.